Security Snapshot

SPDR INDEX SHS FDS - MSCI EMR MKT ETF (EEMX) Institutional Ownership

CUSIP: 78470E205

13F Institutional Holders and Ownership History from Q4 2016 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

49

Shares (Excl. Options)

2,604,302

Price

$44.20

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / MSCI EMR MKT ETF
Symbol
EEMX
Price per share
$48.85
All holders as of 31 Mar 2026
Q1 2026
Total 13F shares
2,604,302
Total reported value
$115,131,860
% of total 13F portfolios
0%
Share change
+1,326,098
Value change
+$58,621,401
Number of holders
49
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Key facts

  • EEMX - SPDR INDEX SHS FDS - MSCI EMR MKT ETF is tracked under CUSIP 78470E205.
  • 49 institutions reported positions in Q1 2026.
  • Schedule 13D/13G significant owner rows are not currently available.

Change

  • Holder count moved from 40 to 49 between Q4 2025 and Q1 2026.
  • Reported value moved from $54,815,904 to $115,131,860.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 49 institutions filings for Q1 2026.

Open SEC Evidence

Security key

78470E205

Latest holder period

Q1 2026

13F holders

49

13D/G owners

0

CIK / CUSIP context first

As of 31 Mar 2026, 49 institutional investors reported holding 2,604,302 shares of SPDR INDEX SHS FDS - MSCI EMR MKT ETF (EEMX).

Institutional Holders of SPDR INDEX SHS FDS - MSCI EMR MKT ETF (EEMX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 2,604,302 $115,131,860 +$58,621,401 $44.20 49
2025 Q4 1,284,499 $54,815,904 +$591,708 $42.64 40
2025 Q3 1,267,001 $53,000,990 -$5,945,647 $41.83 41
2025 Q2 1,413,803 $52,977,673 -$6,300,366 $37.47 40
2025 Q1 1,582,093 $53,143,543 -$384,573 $33.59 37
2024 Q4 1,629,437 $52,627,002 +$1,087,432 $32.30 41
2024 Q3 1,595,181 $56,267,862 -$3,126,550 $35.27 39
2024 Q2 1,692,703 $54,826,034 -$4,471,756 $32.39 41
2024 Q1 1,828,104 $57,326,976 -$878,092 $31.36 39
2023 Q4 1,873,211 $57,697,342 +$507,581 $30.80 42
2023 Q3 1,841,863 $53,414,860 +$5,980,670 $28.99 38
2023 Q2 1,633,343 $49,490,393 -$10,875,191 $30.30 38
2023 Q1 1,996,025 $60,123,110 +$25,747,746 $30.11 39
2022 Q4 1,121,743 $64,348,165 +$1,480,217 $57.39 37
2022 Q3 1,084,961 $60,265,811 -$2,420,614 $53.03 35
2022 Q2 1,134,289 $69,328,376 -$16,557,450 $61.11 36
2022 Q1 1,400,569 $95,893,507 +$42,625,195 $68.44 35
2021 Q4 836,653 $61,242,385 -$2,789,829 $73.18 37
2021 Q3 792,315 $59,236,691 -$378,181 $74.70 33
2021 Q2 796,521 $64,652,740 +$10,829,950 $82.09 35
2021 Q1 665,605 $52,949,311 +$10,786,488 $79.55 31
2020 Q4 529,942 $40,898,000 +$11,169,030 $77.18 23
2020 Q3 386,561 $25,519,107 +$201,547 $66.02 23
2020 Q2 383,690 $22,891,000 +$512,143 $59.67 20
2020 Q1 377,436 $19,264,000 -$10,871,072 $51.04 20
2019 Q4 588,084 $38,568,000 +$9,868,111 $65.58 17
2019 Q3 437,665 $26,178,000 +$17,114,790 $59.81 15
2019 Q2 148,239 $9,276,000 -$7,323,816 $62.58 16
2019 Q1 265,510 $16,585,000 +$2,999,760 $62.47 17
2018 Q4 220,542 $12,521,000 +$2,904,627 $56.74 13
2018 Q3 169,434 $10,644,000 +$6,191,404 $62.76 11
2018 Q2 70,903 $4,489,000 +$1,326,634 $63.67 12
2018 Q1 49,988 $3,544,000 -$2,609,216 $70.81 11
2017 Q4 86,890 $6,065,000 +$4,015,823 $69.79 9
2017 Q3 26,315 $1,727,000 -$1,384,097 $65.78 5
2017 Q2 57,933 $3,590,000 +$3,558,702 $62.05 4
2017 Q1 500 $29,000 -$367,200 $58.00 1
2016 Q4 7,606 $394,000 +$394,000 $52.13 2
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .